EvolveX Accelerator is a sector-agnostic accelerator program that provides early-stage startups with funding, mentorship, and access to a global network of investors and entrepreneurs to help them grow and scale their businesses.
About Evolvex Accelerator
Evolvex Accelerator is an India-based startup accelerator with a generalist mandate across consumer, SaaS, deeptech, and healthtech. Programs of this profile typically run cohort-based equity-for-stipend deals: small initial investments in the USD 25K to USD 100K range in exchange for low single-digit equity, with mentorship, demo day, and an introduction network as the core value proposition. Healthcare exposure is real but light; expect openness to digital health, telemedicine, diagnostics-software, and B2B health SaaS pitched at the Indian market, with limited capacity to underwrite regulated therapeutics or capital-intensive devices. AI focus is opportunistic rather than thematic; AI-native founders are welcome but should not expect specialist diligence or a dedicated AI partner. This is a plausible first stop for very early Indian healthtech founders who need a structured runway, mentor access, and a credentialed first check more than they need a thesis-aligned lead. It is the wrong fit for post-seed companies, US-market-first teams, or founders who already have a priced round in motion. Entry path is the open application on the Evolvex website plus the LinkedIn page for partner outreach. Founders should treat acceptance as the start of a sales motion, not the end of fundraising; the demo day investor list and post-program follow-on connections are what matter, so plan to evaluate the program on cohort outcomes and mentor quality rather than the headline check.
Founder reviews
Other portfolio companies
Companies in Evolvex Accelerator's portfolio not currently in our directory.
- Humors
- SETV
- HealthQ Rehab
Team
Pitch / review this investor
Have you raised from Evolvex Accelerator? Founders only — share your honest experience (anonymous OK, moderated before publishing).